Effects of ONO-2235, an aldose reductase inhibitor, on muscarinic receptors and contractile response of the urinary bladder in rats with streptozotocin-induced diabetes

Japanese Journal of Pharmacology

Volumn 73, Issue 3, 1997, Pages 221-228

  Kanda, Minoru ^a   Eto, Koji ^a   Tanabe, Nobuaki ^a   Sugiyama, Atsushi ^a   Hashimoto, Keitaro ^a   Ueno, Akira ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Aldose reductase inhibitor; Bladder dome (rat); Diabetes mellitus; Muscarinic receptor; Polyol pathway

Indexed keywords

ACETYLCHOLINE; ALDOSE REDUCTASE INHIBITOR; EPALRESTAT; GLUCOSE; MUSCARINIC RECEPTOR; QUINUCLIDINYL BENZILATE; SORBITOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER; BODY WEIGHT; CONTROLLED STUDY; DIURESIS; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; MALE; MUSCLE CONTRACTILITY; MUSCLE CONTRACTION; NONHUMAN; ORAL DRUG ADMINISTRATION; ORGAN WEIGHT; RAT; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SCIATIC NERVE; STREPTOZOCIN DIABETES;

EID: 0030890335     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.73.221     Document Type: Article

References (39)

1. Motzkin D: The significance of deficient bladder sensation. J Urol 100, 445-450 (1968)
2. Buck AC, McRae CU and Chisholm GD: The diabetic bladder. Proc R Soc Med 67, 81-83 (1974)
3. Buck AC, Reed PI, Siddiq YK, Chisholm GD and Fraser TR: Bladder dysfunction and neuropathy in diabetes. Diabetologia 12, 251-258 (1976)
4. Giachetti A: Diabetic neuropathies: pathogenetic mechanisms and therapeutic perspectives. Pharmacol Res Commun 13, 101-109 (1981)
5. Faerman I, Glocer L, Celener D, Jadzinsky M, Fox D, Maler M and Alvarez E: Autonomic nervous system and diabetes. Histological and histochemical study of the autonomic nerve fibers of the urinary bladder in diabetic patients. Diabetes 22, 225-237 (1973)
6. Ellenbeg M: Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92, 321-323 (1980)
7. Ellenberg M and Weber H: The incipient asymptomatic diabetic bladder. Diabetes 16, 331-335 (1967)
8. Khanna OP, Barbieri EJ, Altamura M and McMichael R: Vesicourethral smooth muscle: function and relation to structure. Urology 18, 211-218 (1981)
9. Bassada NK and Finkbeiner AE: Neuropharmacology of the lower urinary tract. In Pharmacology of the Urinary Tract and Male Reproductive System, Edited by Finkbeiner AE, Barbour GL and Bissada NK, pp 199-216, Appleton-Century-Crofts, New York (1982)
10. Lincoln J, Crockett M, Haven AJ and Burnstock G: Rat bladder in the early stages of streptozotocin-induced diabetes: adrenergic and cholinergic innervation. Diabetologia 26, 81-87 (1984)
11. Kolta MG, Wallace LJ and Gerald MC: Streptozotocin-induced diabetes affects rat urinary bladder response to autonomic agents. Diabetes 34, 917-921 (1985)
12. Longhurst PA and Belis JA: Abnormalities of rat bladder contractility in streptozotocin-induced diabetic mellitus. J Pharmacol Exp Ther 238, 773-777 (1986)
13. Latifpour J, Gousse A, Kondo S, Morita T and Weiss RM: Effects of experimental diabetes on biochemical and functional characteristics of muscarinic receptors. J Pharmacol Exp Ther 248, 81-88 (1989)
14. Eika B, Levin RM and Longhurst PA: Collagen and bladder function in streptozotocin-diabetic rats: effects of insulin and aminoguanidine. J Urol 148, 167-172 (1992)
15. Latifpour J, Nishimoto T, Marian MJ, Yoshida M and Weiss RM: Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes. Diabetes 40, 1150-1156 (1991)
16. Fukomoto Y, Yoshida M, Weiss RM and Latifpour J: Reversibility of diabetes- and diuresis-induced alterations in rat bladder dome muscarinic receptors. Diabetes 43, 819-826 (1994)
17. Niakan E, Harati Y and Comstock JP: Diabetic autonomic neuropathy. Metabolism Clin Exp 35, 224-234 (1986)
18. Paro M, Prosdocimi M, Zhang WX, Sutherland G and Sima AA: Autonomic neuropathy in BB rats and alterations in bladder function. Diabetes 38, 1023-1030 (1989)
19. Kikkawa R, Hatanaka I, Yasuda H, Kobayashi N, Shigeta Y, Terashima H, Morimura T and Tsuboshima M: Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene] rhodamine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic rats. Diabetologia 24, 290-292 (1983)
20. Yoshida T, Nishioka H, Yoshioka K, Nakano K, Kondo M and Terashima H: Effect of aldose reductase inhibitor ONO2235 on reduced sympathetic nervous system activity and peripheral nerve disorders in STZ-induced diabetic rats. Diabetes 36, 6-13 (1987)
21. Malone JI, Knox G, Benford S and Tedesco TA: Red cell sorbitol. An indicator of diabetic control. Diabetes 29, 861-864 (1980)
22. Lowry OH, Rosenbrough NJ, Farr AL and Randall RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193, 265-275 (1951)
23. Rosenthal HE: A graphic method for the determination and presentation of binding parameters in complex system. Anal Biochem 20, 525-532 (1967)
24. 50) of an enzyme reaction. Biochem Pharmacol 23, 3099-3108 (1973)
25. Bennet JP Jr and Yamamura HI: Neurotransmitter, hormone, or drug receptor binding methods. In Neurotransmitter Receptor Binding, Edited by Yamamura HI, Enna SJ and Kuhar MJ, pp 61-89, Raven Press, New York (1985)
26. Latifpour J, Gousse A, Yoshida M and Weiss RM: Effect of insulin and dietary myoinositol on muscarinic receptor alterations in diabetic rat bladder. J Urol 147, 760-763 (1992)
27. Stewart MA, Sherman WR, Kurien MM, Moonsammy GI and Wisgerhof M: Polyol accumulation in nervous tissue of rats with experimental diabetes and galactosaemia. J Neurochem 14, 1057-1066 (1967)
28. Greene DA, Lattimer S, Ulbrecht J and Carroll P: Glucose-induced alterations in nerve metabolism: current perspective on the pathogenesis of diabetic neuropathy and future directions for research and therapy. Diabetes Care 8, 290-299 (1985)
29. Uvelius B: Detrusor smooth muscle in rats with alloxan-induced diabetes. J Urol 136, 949-952 (1986)
30. Santicioli P, Gamse R, Maggi CA and Meli A: Cystometric changes in the early phase of streptozotocin-induced diabetes in rats: evidence for sensory changes not correlated to diabetic neuropathy. Naunyn Shmiedebergs Arch Pharmacol 335, 580-587 (1987)
31. Andersson PO, Malmgren A and Uvelius B: Cystometrical and in vitro evaluation of urinary bladder function in rats with streptozotocin-induced diabetes. J Urol 139, 1359-1362 (1988)
32. Moss HE, Lincoln J and Burnstock G: A study of bladder dysfunction during streptozotocin-induced diabetes in the rat using an in vitro whole bladder preparation. J Urol 138, 1279-1284 (1987)
33. Ward JD: Diabetic neuropathy. In International Textbook of Diabetes Mellitus, Edited by Alberti KGMM, DeFronzo RA, Keen H and Zimmet P, pp 1387-1390, John Wiley & Sons, Inc, New York and Chichester (1992)
34. Gabbay KH, Merola LO and Field RA: Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151, 209-210 (1966)
35. Ghahary A, Chakrabarti S, Sima AA and Murphy LJ: Effect of insulin and statil on aldose reductase expression in diabetic rats. Diabetes 40, 1391-1396 (1991)
36. Carpenter FG: Impairment and restoration of rat urinary bladder responsiveness following distension. Am J Physiol 244, R106-R113 (1983)
37. Kudlacz EM, Gerald MC and Wallace LJ: Effects of diabetes and diuresis on contraction and relaxation mechanisms in rat urinary bladder. Diabetes 38, 278-284 (1989)
38. Kudlacz EM, Chun AL, Skau KA, Gerald MC and Wallace LJ: Diabetes and diuretic-induced alterations in function of rat urinary bladder. Diabetes 37, 949-955 (1988)
39. Gabbay KH: The sorbitol pathway and the complications of diabetes. N Engl J Med 288, 831-836 (1973)